Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Merit Medical Systems (MMSI) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to 11.09%.

  • Merit Medical Systems' EBITDA Margin rose 1300.0% to 11.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.31%, marking a year-over-year decrease of 2100.0%. This contributed to the annual value of 11.48% for FY2024, which is 16200.0% up from last year.
  • As of Q3 2025, Merit Medical Systems' EBITDA Margin stood at 11.09%, which was up 1300.0% from 12.26% recorded in Q2 2025.
  • In the past 5 years, Merit Medical Systems' EBITDA Margin registered a high of 13.59% during Q2 2024, and its lowest value of 3.17% during Q2 2021.
  • For the 5-year period, Merit Medical Systems' EBITDA Margin averaged around 9.12%, with its median value being 10.3% (2024).
  • In the last 5 years, Merit Medical Systems' EBITDA Margin surged by 118700bps in 2021 and then tumbled by -13400bps in 2025.
  • Merit Medical Systems' EBITDA Margin (Quarter) stood at 7.86% in 2021, then skyrocketed by 32bps to 10.37% in 2022, then decreased by 0bps to 10.36% in 2023, then decreased by -1bps to 10.3% in 2024, then increased by 8bps to 11.09% in 2025.
  • Its EBITDA Margin stands at 11.09% for Q3 2025, versus 12.26% for Q2 2025 and 11.55% for Q1 2025.